| Trial ID: | L4766 |
| Source ID: | NCT01947790
|
| Associated Drug: |
Pioglitazone Group
|
| Title: |
Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
LVM|Type 2 Diabetic Patients With IHD|Endothelial Function
|
| Interventions: |
DRUG: pioglitazone group|DRUG: Metformin group
|
| Outcome Measures: |
Primary: The changes of LVM, The LVM will be measured at baseline, 6 momth and 9 month | Secondary: The changes of endothelial function, The endothelial function will be measured at baseline, 6 month and 9 month
|
| Sponsor/Collaborators: |
Sponsor: Xiang Guang-da
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
120
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2013-09
|
| Completion Date: |
2015-07
|
| Results First Posted: |
|
| Last Update Posted: |
2015-08-19
|
| Locations: |
Wuhan City, Hubei, 43000, China|Xiang Guangda, Wuhan, Hubei, 430070, China
|
| URL: |
https://clinicaltrials.gov/show/NCT01947790
|
